Published in Cell Biol Toxicol on November 08, 2009
Plasma exposure to insulin glargine and its metabolites M1 and M2 after subcutaneous injection of therapeutic and supratherapeutic doses of glargine in subjects with type 1 diabetes. Diabetes Care (2012) 1.22
Structural and biological properties of the Drosophila insulin-like peptide 5 show evolutionary conservation. J Biol Chem (2010) 0.94
Molecular characterisation of long-acting insulin analogues in comparison with human insulin, IGF-1 and insulin X10. PLoS One (2012) 0.87
Agonism and antagonism at the insulin receptor. PLoS One (2012) 0.81
Reduction of in-stent restenosis risk on nickel-free stainless steel by regulating cell apoptosis and cell cycle. PLoS One (2013) 0.78
Differential Expression of IR-A, IR-B and IGF-1R in Endometrial Physiology and Distinct Signature in Adenocarcinoma. J Clin Endocrinol Metab (2016) 0.75
Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. J Biol Chem (1987) 4.32
Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes (2000) 3.74
Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev (2001) 2.78
Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci U S A (2007) 2.48
Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor. Biochem J (1986) 1.87
Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev (2001) 1.85
Short-term modulation of cell proliferation and apoptosis and preventive/therapeutic efficacy of various agents in a mammary cancer model. Clin Cancer Res (2007) 1.73
Differential signalling potential of insulin- and IGF-1-receptor cytoplasmic domains. EMBO J (1989) 1.64
The functions of insulin signaling: size isn't everything, even in Drosophila. Differentiation (2003) 1.55
Ligand-dependent autophosphorylation of the insulin receptor is positively regulated by Gi-proteins. Biochem J (2004) 1.53
The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia (1994) 1.47
Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction. Horm Res (2001) 1.46
Growth-stimulatory actions of insulin in vitro and in vivo. Endocr Rev (1984) 1.46
A function for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in fibroblasts during mitogenesis: requirement for insulin- and lysophosphatidic acid-mediated signal transduction. Mol Cell Biol (1998) 1.46
Hormone responsive human breast cancer in long-term tissue culture: effect of insulin. Proc Natl Acad Sci U S A (1976) 1.32
Insulin receptor expression and function in human breast cancer cell lines. Cancer Res (1992) 1.31
Mitogenic effect of the insulin analogue glargine in malignant cells in comparison with insulin and IGF-I. Horm Metab Res (2008) 1.30
Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency. Biochem J (1996) 1.27
Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities. Diabetologia (1991) 1.27
Proliferation of colo-357 pancreatic carcinoma cells and survival of patients with pancreatic carcinoma are not altered by insulin glargine. Diabetes Care (2008) 1.26
Insulin as a potent, specific growth factor in a rat hepatoma cell line. Science (1981) 1.24
Reduced expression of the insulin receptor in mouse insulinoma (MIN6) cells reveals multiple roles of insulin signaling in gene expression, proliferation, insulin content, and secretion. J Biol Chem (2004) 1.18
The mitogenic action of insulin-like growth factor I in normal human mammary epithelial cells requires the epidermal growth factor receptor tyrosine kinase. J Biol Chem (2003) 1.18
Cytoplasmic domains determine signal specificity, cellular routing characteristics and influence ligand binding of epidermal growth factor and insulin receptors. EMBO J (1989) 1.17
A superactive insulin: [B10-aspartic acid]insulin(human). Proc Natl Acad Sci U S A (1987) 1.11
Engineering predictability and protraction in a basal insulin analogue: the pharmacology of insulin detemir. Int J Obes Relat Metab Disord (2004) 1.08
Comparison of the mitogenic potency of regular human insulin and its analogue glargine in normal and transformed human breast epithelial cells. Horm Metab Res (2007) 1.05
ASPB10 insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: evidence for enhanced interactions with the insulin-like growth factor-I receptor. Mol Carcinog (1997) 1.02
Recombinant DNA technology in the treatment of diabetes: insulin analogs. Endocr Rev (2001) 1.02
Signaling differences from the A and B isoforms of the insulin receptor (IR) in 32D cells in the presence or absence of IR substrate-1. Endocrinology (2003) 1.01
Logical analysis of timing-dependent receptor signalling specificity: application to the insulin receptor metabolic and mitogenic signalling pathways. Biochem J (1997) 1.01
Overexpression of insulin receptors in fibroblast and ovary cells induces a ligand-mediated transformed phenotype. Mol Endocrinol (1991) 1.00
Insulin glargine and receptor-mediated signalling: clinical implications in treating type 2 diabetes. Diabetes Metab Res Rev (2007) 0.99
Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes. J Biol Chem (1999) 0.98
IGF-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts. Diabetologia (2007) 0.98
The long acting human insulin analog HOE 901: characteristics of insulin signalling in comparison to Asp(B10) and regular insulin. Horm Metab Res (1998) 0.98
The metabolic and mitogenic effects of both insulin and insulin-like growth factor are enhanced by transfection of insulin receptors into NIH3T3 fibroblasts. J Biol Chem (1989) 0.97
Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor. Diabetologia (1997) 0.96
Growth promoting and metabolic activity of the human insulin analogue [GlyA21,ArgB31,ArgB32]insulin (HOE 901) in muscle cells. Eur J Pharmacol (1997) 0.94
Novel insulin analogues and its mitogenic potential. Diabetes Obes Metab (2006) 0.94
Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes. Diabetes (2002) 0.93
Growth of a human breast cancer cell line in serum-free hormone-supplemented medium. Cancer Res (1978) 0.85
Insulin and insulin-like growth factor-I receptors similarly stimulate deoxyribonucleic acid synthesis despite differences in cellular protein tyrosine phosphorylation. Endocrinology (1994) 0.84
Key role of the achievement of an appropriate ribosomal RNA complement for G1-S phase transition in H4-II-E-C3 rat hepatoma cells. J Cell Physiol (2005) 0.84
Insulin-induced proliferation of bladder cancer cells is mediated through activation of the epidermal growth factor system. FEBS J (2006) 0.83
New insulin analogues. Diabetes Technol Ther (2005) 0.82
Differences in the cellular processing of AspB10 human insulin compared with human insulin and LysB28ProB29 human insulin. Metabolism (1999) 0.81
Insulin analogues: impact of cell model characteristics on results and conclusions regarding mitogenic properties. Exp Clin Endocrinol Diabetes (2001) 0.80
The labile nature of the insulin signal(s) for the stimulation of DNA synthesis in mouse lens epithelial and 3T3 cells. J Biol Chem (1987) 0.80
Timing-dependence of insulin-receptor mitogenic versus metabolic signalling: a plausible model based on coincidence of hormone and effector binding. Biochem J (1999) 0.80
Models of insulin action on metabolic and growth response genes. Mol Cell Biochem (1992) 0.80
A transgene coding for a human insulin analog has a mitogenic effect on murine embryonic beta cells. Proc Natl Acad Sci U S A (1995) 0.80
Characterization of the growth of murine fibroblasts that express human insulin receptors. I. The effect of insulin in the absence of other growth factors. Exp Cell Res (1990) 0.78
IRS-4 mediated mitogenic signalling by insulin and growth hormone in LB cells, a murine T-cell lymphoma devoid of IGF-I receptors. Cell Signal (2003) 0.77
Insulin signal transduction by a mutant human insulin receptor lacking the NPEY sequence. Evidence for an alternate mitogenic signaling pathway that is independent of Shc phosphorylation. J Biol Chem (1997) 0.77
Insulin-induced cell cycle progression is impaired in chinese hamster ovary cells overexpressing insulin receptor substrate-3. Endocrinology (2004) 0.76
Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial. Am J Sports Med (2013) 3.89
Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation. Endocrinology (2010) 2.33
Isolation of human antibody repertoires with preservation of the natural heavy and light chain pairing. J Mol Biol (2006) 2.05
Definition of subtypes in the European genotype of porcine reproductive and respiratory syndrome virus: nucleocapsid characteristics and geographical distribution in Europe. Arch Virol (2008) 1.33
Increased phosphorylation of skeletal muscle glycogen synthase at NH2-terminal sites during physiological hyperinsulinemia in type 2 diabetes. Diabetes (2003) 1.13
The genetic diversity of European type PRRSV is similar to that of the North American type but is geographically skewed within Europe. Virology (2002) 1.11
Molecular evolution of PRRSV in Europe: current state of play. Vet Microbiol (2013) 1.03
Structural and biological properties of the Drosophila insulin-like peptide 5 show evolutionary conservation. J Biol Chem (2010) 0.94
Experimental infection with the Paderborn isolate of classical swine fever virus in 10-week-old pigs: determination of viral replication kinetics by quantitative RT-PCR, virus isolation and antigen ELISA. Vet Microbiol (2003) 0.90
HuMax-CD4: a fully human monoclonal anti-CD4 antibody for the treatment of psoriasis vulgaris. Arch Dermatol (2003) 0.87
In situ phosphorylation of Akt and ERK1/2 in rat mammary gland, colon, and liver following treatment with human insulin and IGF-1. Toxicol Pathol (2011) 0.86
Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment. J Clin Endocrinol Metab (2008) 0.86
Generalized cellular hypertrophy is induced by a dual-acting PPAR agonist in rat urinary bladder urothelium in vivo. Toxicol Pathol (2005) 0.85
PPARalpha and PPARgamma are co-expressed, functional and show positive interactions in the rat urinary bladder urothelium. J Appl Toxicol (2010) 0.85
High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression. BMC Cancer (2009) 0.85
Treatment with insulin analog X10 and IGF-1 increases growth of colon cancer allografts. PLoS One (2013) 0.85
Comparison of intracellular signalling by insulin and the hypermitogenic AspB10 analogue in MCF-7 breast adenocarcinoma cells. J Appl Toxicol (2010) 0.83
L-glutamate and glutamine improve haemodynamic function and restore myocardial glycogen content during postischaemic reperfusion: A radioactive tracer study in the rat isolated heart. Clin Exp Pharmacol Physiol (2006) 0.82
Agonism and antagonism at the insulin receptor. PLoS One (2012) 0.81
Trans-species comparison of PPAR and RXR expression by rat and human urothelial tissues. Toxicol Pathol (2008) 0.81
PPAR alpha and PPAR gamma coactivation rapidly induces Egr-1 in the nuclei of the dorsal and ventral urinary bladder and kidney pelvis urothelium of rats. Toxicol Pathol (2009) 0.80
Enhanced dopaminergic differentiation of human neural stem cells by synergistic effect of Bcl-xL and reduced oxygen tension. J Neurochem (2009) 0.80
An alternative method for preparation of tissue sections from the rat mammary gland. Exp Toxicol Pathol (2010) 0.78
MCF-7 human mammary adenocarcinoma cells exhibit augmented responses to human insulin on a collagen IV surface. J Appl Toxicol (2009) 0.78
Systematic evaluation of the metabolic to mitogenic potency ratio for B10-substituted insulin analogues. PLoS One (2012) 0.78
Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathway. Endocr Relat Cancer (2012) 0.78
Allergen-specific polyclonal antibodies reduce allergic disease in a mouse model of allergic asthma. Int Arch Allergy Immunol (2006) 0.77
Identification of stable and oestrus cycle-independent housekeeping genes in the rat mammary gland and other tissues. Vet J (2010) 0.77
Akt2 influences glycogen synthase activity in human skeletal muscle through regulation of NH₂-terminal (sites 2 + 2a) phosphorylation. Am J Physiol Endocrinol Metab (2013) 0.76
Characterization of Porcine Ventral Mesencephalic Precursor Cells following Long-Term Propagation in 3D Culture. Stem Cells Int (2012) 0.76
Flow sorting from organ material by intracellular markers. Cytometry A (2007) 0.76
Unique expression pattern of the three insulin receptor family members in the rat mammary gland: dominance of IGF-1R and IRR over the IR, and cyclical IGF-1R expression. J Appl Toxicol (2011) 0.76
Mammary gland proliferation in female rats: effects of the estrous cycle, pseudo-pregnancy and age. Exp Toxicol Pathol (2010) 0.76
[Stem cell therapy for neurodegenerative disorders]. Ugeskr Laeger (2010) 0.76
Driving gradual endogenous c-myc overexpression by flow-sorting: intracellular signaling and tumor cell phenotype correlate with oncogene expression. Arch Toxicol (2009) 0.75
Authors' response. Am J Sports Med (2013) 0.75
Author's response. Am J Disaster Med (2015) 0.75
Porcine humoral immune responses to multiple injections of murine monoclonal antibodies. APMIS (2005) 0.75